Moira S Cheung

Summary

Affiliation: McGill University
Country: Canada

Publications

  1. doi Osteogenesis Imperfecta: update on presentation and management
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, QC, Canada
    Rev Endocr Metab Disord 9:153-60. 2008
  2. doi Intravenous pamidronate in osteogenesis imperfecta type VII
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    Calcif Tissue Int 84:203-9. 2009
  3. doi Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada
    J Bone Miner Res 26:405-13. 2011
  4. doi Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    Skeletal Radiol 37:465-7. 2008
  5. doi Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 24:669-74. 2009
  6. doi Wormian bones in osteogenesis imperfecta: Correlation to clinical findings and genotype
    Oliver Semler
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    Am J Med Genet A 152:1681-7. 2010
  7. doi The muscle-bone relationship in X-linked hypophosphatemic rickets
    Louis Nicolas Veilleux
    Shriners Hospital for Children and Department of Pediatrics, McGill University, Montreal, Quebec, Canada
    J Clin Endocrinol Metab 98:E990-5. 2013
  8. doi Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate
    Carol Chahine
    From the Faculty of Dentistry, Division of Oral and Maxillofacial Surgery, Montreal, Quebec, Canada
    J Pediatr 153:719-20. 2008
  9. ncbi Natural history of hyperplastic callus formation in osteogenesis imperfecta type V
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 22:1181-6. 2007

Detail Information

Publications9

  1. doi Osteogenesis Imperfecta: update on presentation and management
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, QC, Canada
    Rev Endocr Metab Disord 9:153-60. 2008
    ..Newer more potent forms of bisphosphonates such as zoledronic acid have undergone and are still being subject to international multicentric drug trials and are beginning to replace pamidronate in some centers...
  2. doi Intravenous pamidronate in osteogenesis imperfecta type VII
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    Calcif Tissue Int 84:203-9. 2009
    ..There were no significant side effects noted during the time of follow-up. Thus, intravenous treatment with pamidronate seems to be safe and of some benefit in patients with OI type VII...
  3. doi Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children, Montreal, Quebec, Canada
    J Bone Miner Res 26:405-13. 2011
    ..We did not find evidence for the hypothesis that bisphosphonate treatment protects against skull base abnormalities...
  4. doi Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    Skeletal Radiol 37:465-7. 2008
    ..This case report makes it clear that HPC can lead to significant morbidity, not only in the acute phase but also long term as a result of residual alteration in bone architecture...
  5. doi Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 24:669-74. 2009
    ..It seems more likely that the observed abnormalities in osteoclast morphology are part of the mechanism of action of this drug...
  6. doi Wormian bones in osteogenesis imperfecta: Correlation to clinical findings and genotype
    Oliver Semler
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    Am J Med Genet A 152:1681-7. 2010
    ..Thus, it appears that SNWB occur more frequently in more severely affected OI patients and seem to develop mostly in utero...
  7. doi The muscle-bone relationship in X-linked hypophosphatemic rickets
    Louis Nicolas Veilleux
    Shriners Hospital for Children and Department of Pediatrics, McGill University, Montreal, Quebec, Canada
    J Clin Endocrinol Metab 98:E990-5. 2013
    ..As muscle force and bone mass are usually closely related, we hypothesized that patients with XLH could also have a bone mass deficit in the lower extremities...
  8. doi Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate
    Carol Chahine
    From the Faculty of Dentistry, Division of Oral and Maxillofacial Surgery, Montreal, Quebec, Canada
    J Pediatr 153:719-20. 2008
    ..In the present study, we did not find a case of ONJ among 278 pediatric patients who had received intravenous pamidronate during childhood or adolescence...
  9. ncbi Natural history of hyperplastic callus formation in osteogenesis imperfecta type V
    Moira S Cheung
    Genetics Unit, Shriners Hospital for Children and McGill University, Montreal, Quebec, Canada
    J Bone Miner Res 22:1181-6. 2007
    ..Hyperplastic callus formation was assessed in 23 patients with osteogenesis imperfecta type V. Hyperplastic callus mostly affected long bones in the lower extremities and occurred predominantly during phases of rapid growth...